NK Inhibitory-Receptor Blockade for Purging of Leukemia
NK Inhibitory-Receptor Blockade for Purging of
Leukemia: Effects on Hematopoietic Reconstitution
Crystal Y. Koh, Arati Raziuddin, Lisbeth A. Welniak, Bruce R. Blazar, Michael Bennett,
William J. Murphy
Biology of Blood and Marrow Transplantation 8:17-25 (2002)
© 2002 American Society for Blood and Marrow Transplantation
ABSTRACT:
One of the obstacles of BMT that limits its efficacy is failure to eradicate the original tumor. The incidence of tumor
relapse is particularly high after autologous BMT. Natural killer (NK) cells comprise various subsets that can express
inhibitory receptors for MHC class I determinants. We have recently demonstrated that blockade of NK-cell
inhibitory receptors can augment antitumor effects in vitro and in vivo. However, breakdown of tolerance and autoreactivity
may occur as a result of the inhibition of NK-cell inactivation to self MHC determinants. We have utilized
F(ab)2 fragments of monoclonal antibody, 5E6, against Ly49C/I inhibitory receptors, which are expressed on 35% to
60% of NK cells in H2b strains of mice and are specific for H2Kb, to investigate the effect of inhibitory-receptor
blockade on syngeneic bone marrow cell (BMC) and tumor cell growth. We show that treatment of interleukin
2?activated C57BL/6 (B6, H2b) SCID-mouse NK cells with 5E6 F(ab)2 fragments during 48-hour coculture resulted
in autoreactivity against syngeneic BMCs as demonstrated by suppression of myeloid reconstitution on day 14 post-
BMT. However, this suppressive effect was transient and normalized by day 21 post-BMT. In contrast, blockade of
inhibitory receptors during 24-hour coculture had no adverse effects on myeloid reconstitution after BMT. Furthermore,
under the same coculture conditions, NK cell?mediated purging of C1498 leukemia cells contaminating syngeneic
BMCs was more effective with inhibitory-receptor blockade, leading to a significantly higher proportion of
animals with long-term survival compared to the control recipients. These results demonstrate that short-term in
vitro blockade of inhibitory receptors can augment antitumor activity without long-term inhibitory effects on BMCs
and thus may be of potential use in the purging of contaminating tumor cells prior to autologous BMT.
 Download a PDF version of the full article
 Copyright 1995-2010 - Carden Jennings Publishing Co., Ltd. All rights reserved. The material available at this site is for educational purposes only and is NOT intended for any diagnostic, clinically related, or other purpose. Carden Jennings Publishing Co., Ltd., assumes no responsibility for any use or misuse of this material and makes no warranty or representation of any kind with respect to the material available at this site.
|
|
